木瓜直播

Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care

20% lower risk of VTE observed in large retrospective study of diabetes patients

Existing models improved only slightly after accounting for certain female risk factors

Agency has failed to hold food manufacturers accountable, said Sen. Bernie Sanders

But the drug didn't appear to lower the risk of incident nonproliferative diabetic retinopathy

Experts tackle myths, data bias, and game-changing outcomes of obesity drugs

Eating more dark chocolate was associated with a lower risk of type 2 diabetes

Dual GLP-1/GIP drug yielded an average 47% greater relative weight loss compared to semaglutide

Experts tackle access, equity, and the blockbuster drugs reshaping healthcare

All drugs except one remained more expensive in the U.S.

How GLP-1 drugs are reshaping medicine

In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug

But how to achieve equitable use remains "complicated," says expert

Balancing aspiration risk with the consequences of medication discontinuation